Cynthia Comella to Antiparkinson Agents
This is a "connection" page, showing publications Cynthia Comella has written about Antiparkinson Agents.
Connection Strength
1.628
-
On demand therapy for Parkinson's disease patients: Opportunities and choices. Postgrad Med. 2021 Sep; 133(7):721-727.
Score: 0.730
-
Daytime sleepiness, agonist therapy, and driving in Parkinson disease. JAMA. 2002 Jan 23-30; 287(4):509-11.
Score: 0.189
-
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial. Lancet Neurol. 2013 Aug; 12(8):747-55.
Score: 0.104
-
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study. Mov Disord. 2010 Aug 15; 25(11):1627-32.
Score: 0.086
-
Treatment of early Parkinson's disease. Part 1. Eur Neurol. 2009; 61(4):193-205.
Score: 0.077
-
Treatment of early Parkinson's disease. Part 2. Eur Neurol. 2009; 61(4):206-15.
Score: 0.077
-
Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 2008 Aug 12; 71(7):481-5.
Score: 0.075
-
Parkinson's disease--Part 2: Treatment of motor symptoms. Am J Manag Care. 2008 Mar; 14(2 Suppl):S49-58.
Score: 0.072
-
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology. 2005 Apr 26; 64(8):1450-1.
Score: 0.059
-
Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep. 2003 Mar; 3(2):173-80.
Score: 0.051
-
Effect of medication on EMG patterns in individuals with Parkinson's disease. Mov Disord. 2002 Sep; 17(5):950-60.
Score: 0.049
-
Akathisia in Parkinson's disease. Mov Disord. 1994 Sep; 9(5):545-9.
Score: 0.028
-
Two-year exercise program improves physical function in Parkinson's disease: the PRET-PD randomized clinical trial. Neurorehabil Neural Repair. 2015 Feb; 29(2):112-22.
Score: 0.028